FDA Press Statement || Food and Drug Administration’s (FDA) Commitment to Public Health Protection and Establishment of Technical Working Group (TWG) “Oplan Katharos”
The Food and Drug Administration (FDA) is unwavering in its dedication to safeguarding public health against the proliferation of counterfeit, adulterated, misbranded, and unregistered processed food, devices, drugs, cosmetics, household hazardous […]
FDA Press Statement || Food and Drug Administration’s (FDA) Commitment to Public Health Protection and Establishment of Technical Working Group (TWG) “Oplan Katharos”
The Food and Drug Administration (FDA) is unwavering in its dedication to safeguarding public health against the proliferation of counterfeit, adulterated, misbranded, and unregistered processed food, devices, drugs, cosmetics, household […]
FDA Press Statement || FDA joins #MedSafetyWeek 2023
Play your part in medicines safety. Whether you’re a patient, doctor, nurse, or pharmacist, you can help make medicines safer by reporting side effects to FDA Philippines’ online reporting system. […]
FDA Press Statement || Press Release on the F-Pop Initiative
The Food and Drug Administration (FDA) is pleased to announce the launch of the Functional Pop Beauty “F-Pop” Initiative, a project by the Agency through its Center for Cosmetics and […]
FDA Press Statement || FDA – DTI Price Monitoring at Inspection sa Divisoria 18 August 2023
Nakiisa ang Food and Drug Administration (FDA) sa isinagawang price monitoring and inspection ng Department of Trade and Industry (DTI) sa kahabaan ng Tabora Street, Divisoria Mall, at Sta. Elena […]
FDA Press Statement || Arrest of Chinese national for violation of RA 3720, RA 9711 and the Consumer Act of the Philippines
On June 26, 2023, the Food and Drug Administration North Luzon Regulatory Enforcement Unit (REU) together with the Criminal Investigation and Detection Group (CIDG) RFU3, CIDG Bulacan PFU conducted entrapment […]
FDA Press Statement || Approval of Zuranolone (Zurzuvae™), first oral treatment for postpartum depression (PPD)
On 04 August 2023, the US Food and Drug Administration (US FDA) approved Zuranolone (Zurzuvae™), the first and only oral treatment for postpartum depression (PPD) in adults. PPD is a […]
FDA Press Statement || The FDA Approves the Certificate of Product Registration (CPR) for COVID-19 Vaccine Tozinameran + Famtozinameran (15 mcg/15 mcg)/0.3 mL Dispersion for Booster Injection (IM) for 12 years of age and older.
The FDA Approves the Certificate of Product Registration (CPR) for COVID-19 Vaccine Tozinameran + Famtozinameran (15 mcg/15 mcg)/0.3 mL Dispersion for Booster Injection (IM) for 12 years of age and […]
FDA Press Statement || 06 JULY 2023 – The Food and Drug Administration (FDA) Launches Taskforce Moccus to Facilitate the Evaluation of African Swine Fever (ASF) Vaccine
The Food and Drug Administration (FDA) Director General Dr. Samuel Zacate Launches Taskforce Moccus, which is an Organizational Unit of the Food and Drug Administration which aims to ensure that […]
FDA Press Statement || 21 February 2023 FDA Philippines Launches Task Force Fleming to Make Safe and Effective Covid-19 Drugs More Accessible to All Filipinos.
The Philippine Food and Drug Administration (FDA), an attached agency of the Department of Health (DOH), launched Taskforce Fleming, a specialized program to fast track the provision of safe and […]